BRPI0920617A2 - pílula gota para tratamento de doença de coronária de coração e sua preparação - Google Patents

pílula gota para tratamento de doença de coronária de coração e sua preparação

Info

Publication number
BRPI0920617A2
BRPI0920617A2 BRPI0920617A BRPI0920617A BRPI0920617A2 BR PI0920617 A2 BRPI0920617 A2 BR PI0920617A2 BR PI0920617 A BRPI0920617 A BR PI0920617A BR PI0920617 A BRPI0920617 A BR PI0920617A BR PI0920617 A2 BRPI0920617 A2 BR PI0920617A2
Authority
BR
Brazil
Prior art keywords
preparation
treatment
heart disease
coronary heart
gout pill
Prior art date
Application number
BRPI0920617A
Other languages
English (en)
Inventor
Baoan Gao
Haion Dong
Jianming Chen
Jizhong Zhang
Shunnan Zhang
Wei Li
Xijun Yan
Xinjiang Yan
Ying Zhao
Yonghong Zhu
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of BRPI0920617A2 publication Critical patent/BRPI0920617A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
BRPI0920617A 2008-10-06 2009-09-30 pílula gota para tratamento de doença de coronária de coração e sua preparação BRPI0920617A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200810152009 2008-10-06
PCT/CN2009/074339 WO2010043156A1 (zh) 2008-10-06 2009-09-30 一种治疗冠心病的滴丸及其制备方法

Publications (1)

Publication Number Publication Date
BRPI0920617A2 true BRPI0920617A2 (pt) 2015-12-22

Family

ID=42106231

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920617A BRPI0920617A2 (pt) 2008-10-06 2009-09-30 pílula gota para tratamento de doença de coronária de coração e sua preparação

Country Status (8)

Country Link
US (1) US20110195136A1 (pt)
AP (1) AP2011005679A0 (pt)
AU (1) AU2009304440A1 (pt)
BR (1) BRPI0920617A2 (pt)
CA (1) CA2738614A1 (pt)
IL (1) IL212018A0 (pt)
MX (1) MX2011003647A (pt)
WO (1) WO2010043156A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102657730A (zh) * 2012-06-05 2012-09-12 西藏天力商贸有限公司 一种抗高原反应的红景天口含剂
CN102940694B (zh) * 2012-10-31 2014-06-25 成都医路康医学技术服务有限公司 一种治疗心脑血管病的药物组合物
CN103735617A (zh) * 2013-12-13 2014-04-23 王树林 复方丹参口腔崩解片及其制备方法
CN103800482B (zh) * 2014-03-06 2015-08-12 李兵晖 一种治疗心肌缺血的药物组合物及其制备方法和应用
CN104374844A (zh) * 2014-11-13 2015-02-25 贵州信邦制药股份有限公司 丹参药材中水溶性成分的含量测定方法及其应用
CN106483260A (zh) * 2015-10-09 2017-03-08 厦门中药厂有限公司 一种八宝丹胶囊质量标准控制方法
CN106420836B (zh) * 2016-06-24 2019-10-25 孙彪 一种林蛙油滴丸及其制备方法
CN107596146A (zh) * 2017-10-26 2018-01-19 张纪星 一种治疗冠状动脉粥样硬化和脑血管硬化疾病的中药复方
CN108888707A (zh) * 2018-07-13 2018-11-27 安徽松山堂国药股份有限公司 一种银杏滴丸剂及其制备方法
CN110243988B (zh) * 2019-06-28 2021-09-14 广西中医药大学 壮药白花九里明hplc指纹图谱的建立方法
CN111068368A (zh) * 2020-01-15 2020-04-28 开封嘉骏生物科技有限公司 一种用于沉淀畜禽用中药提取液中杂质的组方及其应用
CN112946118B (zh) * 2021-02-01 2023-04-07 贵州金桥药业有限公司 一种药物指纹图谱的测定方法及其指纹图谱

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1161140C (zh) 2001-11-09 2004-08-11 天津天士力制药股份有限公司 一种预防和治疗冠心病心绞痛的药物及其制备方法和其它用途
CN100553615C (zh) * 2003-12-11 2009-10-28 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物
CN1785247B (zh) * 2004-12-06 2010-08-11 天津天士力制药股份有限公司 一种崩解片及其制备方法

Also Published As

Publication number Publication date
WO2010043156A1 (zh) 2010-04-22
US20110195136A1 (en) 2011-08-11
CA2738614A1 (en) 2010-04-22
IL212018A0 (en) 2011-06-30
MX2011003647A (es) 2011-05-25
AU2009304440A1 (en) 2010-04-22
AP2011005679A0 (en) 2011-04-30

Similar Documents

Publication Publication Date Title
BRPI0920617A2 (pt) pílula gota para tratamento de doença de coronária de coração e sua preparação
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI0807907A2 (pt) co-cristais e composições farmacêuticas compreendendo os mesmos.
CY2016053I2 (el) Μεθοδοι αγωγης χρησιμοποιωντας φαρμακευτικες ουσιες συλληψης αμμωνιας
DK2294012T3 (da) Administration af et tarmrensemiddel og et antibiotika til behandlingen af tarmsygdom
BRPI0814624A2 (pt) Tratamento de doença neurodegenerativa progresiva com ibudilaste
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
BRPI0910626A2 (pt) bocal para terapia de deglutição com pulso de ar e método para sua utilização
DK2172450T3 (da) Nye malonsyre- og sulfonamidderivater og farmaceutisk brug deraf.
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
BRPI1005153A2 (pt) composto, composição farmacêutica, uso de um composto, metodo para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação
BR112013007457A2 (pt) formulações farmacêuticas contendo rifaximina, processos para a sua obtenção e método de tratar doença intestinal
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
BRPI0719202A2 (pt) Diagnóstico e tratamento de câncer usando anticorpo antiereg
BRPI0917432A2 (pt) aparelho de assistência ao coraçâo
BRPI0716466A2 (pt) Tratamento da calda de açúcar
DE06722936T8 (de) Isomerisation pharmazeutischer zwischenprodukte
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
BRPI0813100A2 (pt) Preparação sólida farmacêutica e método de produção da mesma
BRPI1010086A2 (pt) método e produtos para tratamento de doenças
BRPI1009448A2 (pt) combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos
BRPI0912043A2 (pt) métodos de tratamento de doença associada à cinesina meiótica
BRPI0818702A2 (pt) Formulação farmacêutica de ácido clavulânico
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]